<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Boston, Massachusetts–(Newsfile Corp. – October 21, 2021) – Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Novavax, Inc. (“Novavax” or the “Company”) (NASDAQ: NVAX), a biotechnology company with headquarters in Gaithersburg, Maryland. Novavax purports to be “conducting late-stage clinical trials for NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19.”On October 19, 2021, after the market closed, Politico published an article, entitled “‘They Rushed…
...read full article on Newsfile Corp
